Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial

M.G. Bousser; P. Amarenco; A. Chamorro; M. Fisher; I. Ford; K.M. Fox; M.G. Hennerici; H.P. Mattle; P.M. Rothwell; A. de Cordoue; L.J. Kappelle; X. PERFORM Study Investigators; M.D. Fratacci

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial

Translated title of the contribution: Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial

M.G. Bousser
, P. Amarenco
, A. Chamorro
, M. Fisher
, I. Ford
, K.M. Fox
, M.G. Hennerici
, H.P. Mattle
, P.M. Rothwell
, A. de Cordoue
, L.J. Kappelle
, X. PERFORM Study Investigators
, M.D. Fratacci

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
Original language	Undefined/Unknown
Pages (from-to)	2013-2022
Number of pages	10
Journal	The Lancet
Volume	377
Issue number	9782
Publication status	Published - 2011

Keywords

Econometric and Statistical Methods: General
Geneeskunde(GENK)
Medical sciences
Bescherming en bevordering van de menselijke gezondheid

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/21616527

Cite this

Bousser, M. G., Amarenco, P., Chamorro, A., Fisher, M., Ford, I., Fox, K. M., Hennerici, M. G., Mattle, H. P., Rothwell, P. M., de Cordoue, A., Kappelle, L. J., PERFORM Study Investigators, X., & Fratacci, M. D. (2011). Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. The Lancet, 377(9782), 2013-2022. http://www.ncbi.nlm.nih.gov/pubmed/21616527

@article{ce115121708d4e5ba86303b6760c1827,

title = "Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial",

keywords = "Econometric and Statistical Methods: General, Geneeskunde(GENK), Medical sciences, Bescherming en bevordering van de menselijke gezondheid",

author = "M.G. Bousser and P. Amarenco and A. Chamorro and M. Fisher and I. Ford and K.M. Fox and M.G. Hennerici and H.P. Mattle and P.M. Rothwell and \{de Cordoue\}, A. and L.J. Kappelle and \{PERFORM Study Investigators\}, X. and M.D. Fratacci",

year = "2011",

language = "Undefined/Unknown",

volume = "377",

pages = "2013--2022",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "9782",

}

Bousser, MG, Amarenco, P, Chamorro, A, Fisher, M, Ford, I, Fox, KM, Hennerici, MG, Mattle, HP, Rothwell, PM, de Cordoue, A, Kappelle, LJ, PERFORM Study Investigators, X & Fratacci, MD 2011, 'Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial', The Lancet, vol. 377, no. 9782, pp. 2013-2022. <http://www.ncbi.nlm.nih.gov/pubmed/21616527>

TY - JOUR

T1 - Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial

AU - Bousser, M.G.

AU - Amarenco, P.

AU - Chamorro, A.

AU - Fisher, M.

AU - Ford, I.

AU - Fox, K.M.

AU - Hennerici, M.G.

AU - Mattle, H.P.

AU - Rothwell, P.M.

AU - de Cordoue, A.

AU - Kappelle, L.J.

AU - PERFORM Study Investigators, X.

AU - Fratacci, M.D.

PY - 2011

Y1 - 2011

KW - Econometric and Statistical Methods: General

KW - Geneeskunde(GENK)

KW - Medical sciences

KW - Bescherming en bevordering van de menselijke gezondheid

M3 - Article

SN - 0140-6736

VL - 377

SP - 2013

EP - 2022

JO - The Lancet

JF - The Lancet

IS - 9782

ER -